Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 13
Mild 14
None 12

Commonly reported side effects and conditions associated with Bortezomib

Side effect Patients Percentage
Fatigue 7
Constipation 4
Peripheral neuropathy 4
Chronic constipation 2
Dizziness 2
Neuropathy in feet 2

Show all 30 reported side effects

Dosages

Based on patients currently taking Bortezomib

Dosage Patients Percentage
3.5 mg monthly 1
3.5 mg weekly 1

Why patients stopped taking Bortezomib

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 13
Course of treatment ended 11
Side effects too severe 7
Other 4
Did not seem to work 3
See all 29 patients who've stopped taking Bortezomib

Duration

Currently taking Bortezomib

Duration Patients Percentage
2 - 5 years 1
5 - 10 years 1

Stopped taking Bortezomib

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 8
6 months - 1 year 7
1 - 2 years 5
2 - 5 years 5
Adherence
Adherence Evaluations Percentage
Always 41
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 4
A little hard to take 11
Not at all hard to take 28
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 3
$25-49 0
< $25 11
Not specified 28

What people switch to and from

Patients started taking Bortezomib after stopping:

Treatment Patients Percentage
Lenalidomide (Revlimid) 5
Lenalidomide-dexamethasone (Rd) 2
Bortezomib-lenalidomide-dexamethasone (VRd) 1
Dexamethasone (Decadron) 1

Patients stopped taking Bortezomib and switched to:

Treatment Patients Percentage
Carfilzomib (Kyprolis) 3
Lenalidomide (Revlimid) 3
Daratumumab (Darzalex) 2
Dexamethasone (Decadron) 1
Elotuzumab (Empliciti) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Bortezomib.